Association between donor-specific antibodies and acute rejection and resolution in small bowel and multivisceral transplantation

Transplantation

Volumn 92, Issue 6, 2011, Pages 709-715

  Tsai, Hsin Lin ^a,b   Island, Eddie R ^a,c   Chang, Jei Wen ^a,b   Gonzalez Pinto, Ignacio ^a,d   Tryphonopoulos, Panagiotis ^a   Nishida, Seigo ^a   Selvaggi, Gennaro ^a   Tekin, Akin ^a   Moon, Jang ^a   Levi, David ^a   Woodle, E Steve ^e   Ruiz, Phillip ^a   Weppler, Debbie ^a   Lee, Oscar K S ^b   Tzakis, Andreas G ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^d HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^e UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Acute rejection; Donor specific antibody; Multivisceral transplantation; Small bowel transplantation

Indexed keywords

ALEMTUZUMAB; ANTIBODY; BORTEZOMIB; DONOR SPECIFIC ANTIBODY; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN; METHYLPREDNISOLONE; OKT 3; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; GASTROINTESTINAL MOTILITY DISORDER; GASTROINTESTINAL SURGERY; GRAFT FAILURE; HUMAN; ILEUM; INCIDENCE; INFANT; INTESTINE BIOPSY; INTESTINE GRAFT; INTESTINE TRANSPLANTATION; MULTIVISCERAL TRANSPLANTATION; NECROTIZING ENTEROCOLITIS; ORGAN TRANSPLANTATION; PANCREAS TUMOR; PLASMAPHERESIS; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SUPERIOR MESENTERIC ARTERY OBSTRUCTION;

ADOLESCENT; ADULT; ANTIBODIES; BIOPSY; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GRAFT REJECTION; HLA ANTIGENS; HUMANS; INTESTINE, SMALL; INTESTINES; MALE; MIDDLE AGED; TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 80052688843     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318229f752     Document Type: Article

References (28)

1. Fishbein TM. Intestinal transplantation. N Engl J Med 2009; 361: 998.
2. Ruiz P, Garcia M, Pappas P, et al. Mucosal vascular alterations in isolated small-bowel allografts: Relationship to humoral sensitization. Am J Transplant 2003; 3: 43.
3. Kato T, Mizutani K, Terasaki P, et al. Association of emergence of HLA antibody and acute rejection in intestinal transplant recipients: A possible evidence of acute humoral sensitization. Transplant Proc 2006; 38: 1735.
4. Ruiz P, Carreno M, Weppler D, et al. Immediate antibody-mediated (hyperacute) rejection in small-bowel transplantation and relationship to cross-match status and donor-specific C4d-binding antibodies: Case report. Transplant Proc 2010; 42: 95.
5. Gloor JM, Winters JL, Cornell LD, et al. Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation. Am J Transplant 2010; 10: 582.
6. Lachmann N, Terasaki PI, Budde K, et al. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts. Transplantation 2009; 87: 1505.
7. Gibney EM, Cagle LR, Freed B, et al. Detection of donor-specific antibodies using HLA-coated microspheres: Another tool for kidney transplant risk stratification. Nephrol Dial Transplant 2006; 21: 2625.
8. Hidalgo LG, Campbell PM, Sis B, et al. De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am J Transplant 2009; 9: 2532.
9. Wu T, Abu-Elmagd K, Bond G, et al. A clinicopathologic study of isolated intestinal allografts with preformed IgG lymphocytotoxic antibodies. Transplant Proc 2002; 34: 878.
10. Wu T, Abu-Elmagd K, Bond G, et al. A clinicopathologic study of isolated intestinal allografts with preformed IgG lymphocytotoxic antibodies. Hum Pathol 2004; 35: 1332.
11. Bond G, Reyes J, Mazariegos G, et al. The impact of positive T-cell lymphocytotoxic crossmatch on intestinal allograft rejection and survival. Transplant Proc 2000; 32: 1197.
12. Grant D, Abu-Elmagd K, Reyes J, et al. 2003 Report of the intestine transplant registry a new era has dawned. Ann Surg 2005; 241: 607.
13. Toyama N, Kobayashi E, Yamada S, et al. Fulminant second-set allograft rejection and endoscopic findings following small bowel transplantation in the rat. J Gastroenterol 1995; 30: 465.
14. Abu-Elmagd K, Reyes J, Todo S, et al. Clinical intestinal transplantation: New perspectives and immunologic considerations. J Am Coll Surg 1998; 186: 512.
15. Gondolesi G, Blondeau B, Maurette R, et al. Pretransplant immunomodulation of highly sensitized small bowel transplant candidates with intravenous immune globulin. Transplantation 2006; 81: 1743.
16. de Serre NP, Canioni D, Lacaille F, et al. Evaluation of C4d deposition and circulating antibody in small bowel transplantation. Am J Transplant 2008; 8: 1290.
17. Rodriguez ER, Skojec DV, Tan CD, et al. Antibody-mediated rejection in human cardiac allografts: Evaluation of immunoglobulins and complement activation products C4d and C3d as markers. Am J Transplant 2005; 5: 2778.
18. Martinu T, Chen DF, Palmer SM. Acute rejection and humoral sensitization in lung transplant recipients. Proc Am Thorac Soc 2009; 6: 54.
19. Ruiz JO, Uchida H, Schultz LS, et al. Problems in absorption and immunosuppression after entire intestinal allotransplantation. Am J Surg 1972; 123: 297.
20. Pappas PA, Saudubary JM, Tzakis AG, et al. Serum citrulline and rejection in small bowel transplantation: A preliminary report. Transplantation 2001; 15: 1212.
21. Cicalese L, Freeswick PD, Watkins SC, et al. Use of CD14 and lipopolysaccharide binding protein mRNA expression as markers for acute rejection in rat small bowel transplantation. Transplant Proc 1996; 28: 2470. (Pubitemid 26339347)
22. Sudan D, Vargas L, Sun Y, et al. Calprotectin a novel noninvasive marker for intestinal allograft monitoring. Ann Surg 2007; 246: 311.
23. Morales-Buenrostro LE, Terasaki PI, Marino-Vázquez LA, et al. "Natural" human leukocyte antigen antibodies found in nonalloimmunized healthy males. Transplantation 2008; 86: 1111.
24. Singh N, Pirsch J, Samaniego M. Antibody-mediated rejection: Treatment alternatives and outcomes. Transplant Rev 2009; 23: 34.
25. Walsh RC, Everly JJ, Brailey P, et al. Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection. Transplantation 2010; 89: 277.
26. Island ER, Gonzalez-Pinto IM, Tsai HL, et al. Successful treatment with bortezomib of a refractory humoral rejection of the intestine after multivisceral transplantation. Clin Transpl. 2009: 465.
27. Zeevi A, Lunz JG III, Shapiro R, et al. Emerging role of donor-specific anti-human leukocyte antigen antibody determination for clinical management after solid organ transplantation. Hum Immunol 2009; 70: 645.
28. Everly MJ, Everly JJ, Arend LJ, et al. Reducing de novo donor-specific antibody levels during acute rejection diminishes renal allograft loss. Am J Transplant 2009; 9: 1063.